1. Home
  2. DLB vs BCPC Comparison

DLB vs BCPC Comparison

Compare DLB & BCPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dolby Laboratories

DLB

Dolby Laboratories

HOLD

Current Price

$53.49

Market Cap

5.8B

Sector

Miscellaneous

ML Signal

HOLD

Logo Balchem Corporation

BCPC

Balchem Corporation

HOLD

Current Price

$170.94

Market Cap

5.6B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
DLB
BCPC
Founded
1965
1967
Country
United States
United States
Employees
N/A
N/A
Industry
Multi-Sector Companies
Major Chemicals
Sector
Miscellaneous
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
5.8B
5.6B
IPO Year
2004
1995

Fundamental Metrics

Financial Performance
Metric
DLB
BCPC
Price
$53.49
$170.94
Analyst Decision
Strong Buy
Buy
Analyst Count
4
2
Target Price
$90.75
$176.00
AVG Volume (30 Days)
810.1K
202.9K
Earning Date
04-30-2026
04-30-2026
Dividend Yield
2.28%
0.55%
EPS Growth
N/A
20.87
EPS
1.54
1.25
Revenue
N/A
$799,023,000.00
Revenue This Year
$6.22
$8.47
Revenue Next Year
$3.84
$4.89
P/E Ratio
$34.08
$135.33
Revenue Growth
N/A
13.56
52 Week Low
$50.73
$139.17
52 Week High
$76.91
$183.90

Technical Indicators

Market Signals
Indicator
DLB
BCPC
Relative Strength Index (RSI) 46.15 68.30
Support Level $52.45 $167.19
Resistance Level $65.73 $171.50
Average True Range (ATR) 1.43 3.13
MACD 0.20 1.05
Stochastic Oscillator 64.13 91.90

Price Performance

Historical Comparison
DLB
BCPC

About DLB Dolby Laboratories

Dolby Laboratories Inc. develops technologies that enhance audio and video capture, transmission, and playback, enabling high-quality experiences across movies, TV, music, sports, and more. The company designs and manufactures audio, imaging, accessibility, and related hardware and software mainly for cinema, including digital cinema servers and media encryption and packaging tools. It generates the majority of its revenue by licensing its technology, brand, and patents to device manufacturers and by selling cinema hardware and services. It operates as a single reportable segment, with revenue derived mainly from licensing and, to a lesser extent, from premium cinema technologies, across the United States and international markets.

About BCPC Balchem Corporation

Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.

Share on Social Networks: